National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

dornase alfa inhalation solution (DOR-nayz AL-fuh in-huh-LAY-shun suh-LOO-shun)

 A drug given in an aerosol mist to decrease the thickness of mucus in the lungs of patients with cystic fibrosis. It is also being studied as a treatment to reduce the thickness of saliva in patients being treated for head and neck cancer. Dornase alfa inhalation solution contains an enzyme that breaks the DNA in mucus into small pieces and makes the mucus thinner. Also called Pulmozyme.



Previous Definitions:dolasetron mesylate, dolastatin 10, donepezil, dong quai, donor lymphocyte infusion
Next Definitions:dose, dose-dense chemotherapy, dose-dependent, dose-limiting, dose-rate

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov